Striant Articles
ProStrakan’s Sancuso out-licensed by Solasia in Asia
4 March 2010
Belgium’s UCB to maximize US focus and resources on core products, hiving off primary care to Sanofi and Teva
1 February 2010
Ph III results support Boehringer Ingelheim’s flibanserin as a potential female “Viagra”
17 November 2009
Alvogen acquires R&D capabilities and enters into multi-product development deal with Par Pharmaceutical
23 October 2009
Robert Wessman and Alvogen Group combine to build a leading international generics company
29 July 2009
Teikoku USA acquires Travanti Pharma
1 June 2009
Profit plummets 55% for Solvay in recession
15 May 2009
ProStrakan files response to FDA
7 May 2009
Ferring initiates prostate cancer trial
30 April 2009
J&J 1st qtr hit by market drop; keeps guidance
15 April 2009
Zosano patch equivalent to Lilly's Forteo
8 April 2009
Altea in Lilly/Amylin deal for diabetes patch
7 April 2009
Indus Biotech partners on sports supplement
6 April 2009
Shire recalls 39 lots of Daytrana due to design flaws
30 March 2009
ProStrakan's 2008 revenue up 23%
30 March 2009
AGI's CID drug shows benefit at higher dose
23 March 2009
Endo files response for Nebido application
23 March 2009
Shire withdaws EU Daytrana MAA
23 March 2009
Teikoku to help Eisai develop donepezil skin patch
16 March 2009
Japan stock market week to Mar 9, 2009
16 March 2009
Endo set to return rights to painkiller skin patch
16 March 2009
MRI danger for Teva patch and others
16 March 2009
Ferring gets EC nod for testosterone blocker
2 March 2009
Leconotide's potential for non-opioid pain relief
9 February 2009
FDA asks UCB to solve Neupro formulation
12 January 2009
Ferring receives FDA approval for degarelix
12 January 2009
Ferring's Firmagon OKed by CHMP
12 January 2009
FDA approves Ferring's cancer castration drug
12 January 2009
Stock Commentary - New York week to Dec 15, 2008
22 December 2008
Zosano complete end-of-Ph II ZP-PTH meeting with FDA
15 December 2008
Bayer signs deal for ProStrakan's Tostrex
15 December 2008
Ferring is Auxilium's new EU partner for Testim
8 December 2008
ProStrakan licenses Tostran to Bayer
1 December 2008
ProStrakan's 10-month sales jump 33%
24 November 2008
BioSante gets NIH grant for inhaled interferon
24 November 2008
US FDA accepts Debiopharm's Trelstar NDA for filing
24 November 2008
Vivus' 3rd-qtr profit drops 79% on R&D costs
17 November 2008
ProStrakan's Sancuso launched in USA
10 November 2008
ProStrakan partners with NewBridge for Sancuso
10 November 2008
US FDA approves Teva's fentanyl patch
27 October 2008
Japan stock market week to Oct 20, 2008
27 October 2008
FDA and Indevus agree over Nebido NDA
6 October 2008
Durect licenses Eldur patch to Alpharma
6 October 2008
EpiCept amends deal with Durect
22 September 2008
Zosano sees good results for PTH Patch
22 September 2008
AGI's loss deepens on flat revenue
22 September 2008
Syntropharma raises $2.4M in second round of investment
15 September 2008
Noven in global deal with P&G on HSDD patch
1 September 2008
Solvay debuts web site on low testosterone awareness
1 September 2008
Study may explain sex hormone/body fat link
1 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
KV to use Acrux' spray for six new products
1 September 2008
Vivus returns to profit on Evamist gain
1 September 2008
BioSante reacquires Elestrin rights
18 August 2008
Noven gets final $25M Shire milestone
11 August 2008
Vyteris to pursue joint developments in pain mangement
11 August 2008
Ph III salmon calcitonin trial completes recruitment
11 August 2008
BioSante gains new FDA SPA for Libigel
4 August 2008
Japan stock market week to June 23, 2008
30 June 2008
Lilly pays $35M for TP's osteoperosis patch
23 June 2008
Axxonis submits MAA for Nenad
9 June 2008
Nuvo licenses pain product from Paladin
9 June 2008
FDA accepts NDA on Watson's OAB gel
9 June 2008
Watson presents data on Ph III urology products
2 June 2008
ProStrakan's early-2008 sales exceed projections
2 June 2008
JapanBridge to market Sancuso in SE Asia
2 June 2008
UCB report is cagey about interim results
26 May 2008
Debiopharm signs Salvacyl market deal
26 May 2008
Solvay's 1st-qtr 2008 net income rises 1%
26 May 2008
Watson's 1st-qtr 2008 net income jumps 60%
12 May 2008
Burdica launches L2M fundraising program
21 April 2008
Urigen terminates nasal testosterone spray deal
14 April 2008
Strong Ph II data for Ardana's Teverelix LA
14 April 2008
UCB drops 12% on Neupro batches recall
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
Levitra helps ED patients with high cholesterol
31 March 2008
Vivus posts $10M 4th-qtr 2007 profit
24 March 2008
Ferring files degarelix as prostate cancer therapy
10 March 2008
UCB's 2007 net profit down 59% on M&A
10 March 2008
SEP launches Plenaxis in Germany
3 March 2008
Watson swings to profit of $38.4M in 4th qtr
3 March 2008
Ardana unveils plans to seek buyer
25 February 2008
J&J/Actavis recall US lots of fentanyl patches
25 February 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
